Patients undergoing spinal fusion surgery with bone morphogenetic protein appear to be at increased risk of benign tumors — but not cancers.
Patients undergoing spinal fusion surgery with bone morphogenetic protein appear to be at increased risk of benign tumors — but not cancers.